Real-World Experience With the WEB Device for Intracranial Aneurysms

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The WEB-RWS is a multicenter, ambispective registry that collects real-world safety and effectiveness data on commercially available Woven EndoBridge devices used in standard clinical practice. It includes retrospective and prospective cohorts with centralized data capture, independent adjudication of safety events, and core-lab assessment of imaging outcomes. The primary goal is to measure 12-month adequate aneurysm occlusion and major adverse events after WEB treatment. The study aims to provide post-market evidence on safety, effectiveness, clinical suitability, and health economic value in routine neurointerventional care in China.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Retrospective Cohort:

* Participants of any age and sex.
* Patients treated for an intracranial aneurysm using a commercially available MicroVention Woven EndoBridge device.
* Patients who completed at least one postoperative imaging follow-up.

Prospective Cohort:

* Participants of any age and sex.
* Patients treated for an intracranial aneurysm using a commercially available MicroVention Woven EndoBridge device.
* The participant, or legally authorized representative if applicable, understands the study requirements and procedures and provides written informed consent before any study-specific data collection.

Exclusion Criteria:

Retrospective Cohort:

* Patients treated with a Woven EndoBridge device for whom intraoperative or postoperative follow-up imaging data are not available.
* Patients considered by the investigator to be unsuitable for participation in this study.

Prospective Cohort:

* Participants who are currently participating in, or plan to participate during the follow-up period, another clinical study that may affect the results of this study.
* Patients who are currently unable or expected to be unable to complete follow-up.
* Patients with a life expectancy of less than 1 year due to other diseases or conditions.
* Patients considered by the investigator to be unsuitable for participation in this study.

Where it's running

• Xuanwu Hospital
  Beijing, China Recruiting

Study contacts

• Principal investigator: Xin Su — Xuanwu Hospital, Beijing
• Study coordinator: Hongqi Zhang, M.D
• Email: xwzhanghq@163.com
• Phone: +8613601374152

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Flow Diverter Stent for Intracranial Aneurysm in China

  This study tests a novel flow diverter stent to treat intracranial aneurysms in adults and follows patients through treatment and follow-up.

  Recruiting Beijing Tiantan Hospital · Beijing, Beijing Municipality · NCT07821957

• Choydar flow-directed mesh stent for unruptured brain aneurysms

  This trial tests the Choydar flow-directed mesh stent to see if it is safe and works for people with unruptured intracranial aneurysms in the internal carotid or vertebral arteries.

  Recruiting at 8 sites Johnson & Johnson Medical (Shanghai) Ltd. · Chenzhou and 7 other locations · NCT07228312

• Pivotal test of the Silk Vista Baby Flow Diverter for unruptured brain aneurysms

  This study tests whether the Silk Vista Baby flow diverter can safely and effectively treat a single unruptured intracranial aneurysm in adults 22–80 years old.

  Recruiting at 6 sites Balt USA · Thousand Oaks, California and 5 other locations · NCT07225075

• Pipeline Vantage post-approval safety and outcomes for intracranial aneurysm treatment

  This project will test whether the Pipeline Vantage embolization device with Shield Technology is safe and effective for adults treated for intracranial aneurysms.

  Recruiting at 10 sites Medtronic Neurovascular Clinical Affairs · Jacksonville, Florida and 9 other locations · NCT06604884

• Improving brain intervention planning using vascular mapping

  This study is testing new ways to plan brain surgeries for aneurysms and AVMs to make them safer and more effective by using advanced mapping and computer models.

  Recruiting University Hospital, Ghent · Ghent · NCT06588543

• Collecting real-life data on endovascular treatments for brain aneurysms

  This study is collecting real-life information on how safe and effective a specific type of device is for treating brain aneurysms in patients.

  Recruiting Microvention-Terumo, Inc. · Vigo, Pontevedra · NCT06494436

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.